COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 195 filers reported holding COHERUS BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,156,075 | +12475.6% | 309,111 | +14257.2% | 0.00% | – |
| Q2 2023 | $9,193 | -99.3% | 2,153 | -99.0% | 0.00% | -100.0% |
| Q1 2023 | $1,405,018 | -42.0% | 205,412 | -32.8% | 0.00% | 0.0% |
| Q4 2022 | $2,420,740 | +460.4% | 305,649 | +579.9% | 0.00% | – |
| Q3 2022 | $432,000 | -48.6% | 44,952 | -61.3% | 0.00% | – |
| Q2 2022 | $841,000 | -37.2% | 116,098 | +11.8% | 0.00% | – |
| Q1 2022 | $1,340,000 | -48.7% | 103,861 | -36.6% | 0.00% | -100.0% |
| Q4 2021 | $2,613,000 | +32.4% | 163,692 | +33.3% | 0.00% | 0.0% |
| Q3 2021 | $1,973,000 | +171.4% | 122,762 | +133.5% | 0.00% | – |
| Q2 2021 | $727,000 | -58.9% | 52,584 | -56.6% | 0.00% | -100.0% |
| Q1 2021 | $1,771,000 | +701.4% | 121,222 | +850.0% | 0.00% | – |
| Q4 2020 | $221,000 | -25.8% | 12,760 | -21.4% | 0.00% | – |
| Q3 2020 | $298,000 | -30.9% | 16,235 | -32.8% | 0.00% | – |
| Q2 2020 | $431,000 | -34.9% | 24,154 | -40.8% | 0.00% | – |
| Q1 2020 | $662,000 | -27.3% | 40,802 | -19.3% | 0.00% | – |
| Q4 2019 | $910,000 | +6.3% | 50,561 | +19.6% | 0.00% | – |
| Q3 2019 | $856,000 | -41.7% | 42,283 | -36.3% | 0.00% | -100.0% |
| Q2 2019 | $1,468,000 | +304.4% | 66,424 | +149.4% | 0.00% | – |
| Q1 2019 | $363,000 | -80.7% | 26,630 | -87.2% | 0.00% | -100.0% |
| Q4 2018 | $1,883,000 | +299.8% | 208,034 | +628.9% | 0.00% | – |
| Q3 2018 | $471,000 | -28.1% | 28,542 | -39.0% | 0.00% | – |
| Q2 2018 | $655,000 | -26.7% | 46,763 | -42.2% | 0.00% | – |
| Q1 2018 | $894,000 | +831.2% | 80,902 | +642.1% | 0.00% | – |
| Q4 2017 | $96,000 | -59.8% | 10,902 | -39.4% | 0.00% | – |
| Q3 2017 | $239,000 | +39.8% | 17,985 | +51.9% | 0.00% | – |
| Q2 2017 | $171,000 | +194.8% | 11,837 | +333.6% | 0.00% | – |
| Q1 2017 | $58,000 | -89.1% | 2,730 | -85.6% | 0.00% | – |
| Q4 2016 | $534,000 | +314.0% | 18,981 | +292.9% | 0.00% | – |
| Q3 2016 | $129,000 | +92.5% | 4,831 | +22.0% | 0.00% | – |
| Q2 2016 | $67,000 | +378.6% | 3,960 | +554.5% | 0.00% | – |
| Q4 2015 | $14,000 | -82.5% | 605 | -78.2% | 0.00% | – |
| Q2 2015 | $80,000 | +2.6% | 2,777 | +8.9% | 0.00% | – |
| Q1 2015 | $78,000 | +609.1% | 2,551 | +272.4% | 0.00% | – |
| Q4 2014 | $11,000 | – | 685 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |